Send SMS    Call Me Free
Cabazitaxel

Cabazitaxel

Product Details:

  • Formulations Type Injectables
  • Formulations Form Liquid
  • Gender/Age Group Adult
  • Click to view more
X

Product Specifications

  • Injectables
  • Liquid
  • Adult

Trade Information

  • Cash on Delivery (COD), Cash Advance (CA), Delivery Point (DP), Western Union
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid.[1] It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.[2][unreliable source?]

Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment.


JOHNLEE PHARMACEUTICALS PVT. LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



JOHNLEE PHARMACEUTICALS PVT. LTD. All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.